GN
Therapeutic Areas
IHP Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| IHP-102 | Acute vaso-occlusive crisis in sickle cell disease | Pre-clinical |
Leadership Team at IHP Therapeutics
RG
Rinko Ghosh
President and CEO
JP
John Paderi
Chief Scientific Officer
KS
Kate Stuart
VP of Program Management